Dr. Burtness on Challenges Facing Immunotherapy in Head and Neck

Barbara Burtness, MD, professor of medicine, Yale Cancer Center, discusses challenges regarding immunotherapy for patients with head and neck cancer.

Although immunotherapy can lead to durable responses, there are still a population of patients who do not see any responses, explains Burtness.

According to Burtness, more research needs to be conducted in an attempt to make all patients respond to immunotherapy or to determine a targeted therapy to better support the immune system.